412
Views
4
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation

A safety evaluation of budesonide MMX for the treatment of ulcerative colitis

, , , , &
Pages 437-444 | Received 15 Jan 2018, Accepted 12 Feb 2018, Published online: 23 Feb 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Amin Abbasi, Neda Hajipour, Paniz Hasannezhad, Amir Baghbanzadeh & Leili Aghebati-Maleki. (2022) Potential in vivo delivery routes of postbiotics. Critical Reviews in Food Science and Nutrition 62:12, pages 3345-3369.
Read now

Articles from other publishers (3)

Giovanni Maconi, Nicolò Mezzina, Stefano Landi, Simone Grillo, Cristina Bezzio, Matteo Bosani, Luca Pastorelli, Alessandra Dell'Era, Richa Chibbar, Stefania Carmagnola, Paola Molteni, Andrea Cassinotti, Alessandro Massari & Sandro Ardizzone. (2019) Use, effectiveness and tolerability of budesonide‐MMX in ulcerative colitis: A real‐life experience. United European Gastroenterology Journal 7:9, pages 1164-1170.
Crossref
Panna Vass, Balázs Démuth, Edit Hirsch, Brigitta Nagy, Sune K. Andersen, Tamás Vigh, Geert Verreck, István Csontos, Zsombor K. Nagy & György Marosi. (2019) Drying technology strategies for colon-targeted oral delivery of biopharmaceuticals. Journal of Controlled Release 296, pages 162-178.
Crossref
Amichai Perlman, Alexander Maly & Zvi Ackerman. (2018) Skin Hypersensitivity to Oral Budesonide: Case Report and Review of the FDA Adverse Event Reporting System Database. Annals of Pharmacotherapy 52:10, pages 1049-1050.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.